LLY vs HUM
By Alex · Tickerpine
Eli Lilly and Company vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | HUM |
|---|---|---|
| Price | $1,443.50 | $450.00 |
| Market cap | $1.29T | $54.05B |
| P/E ratio | 46.9 | 43.9 |
| ROE | 86.02% | 6.74% |
| Profit margin | 31.90% | 0.81% |
| Revenue growth | 38.60% | 26.10% |
| Dividend yield | 0.48% | 0.79% |
| Beta | 0.39 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs HUM in plain English
- LLY is the bigger company — about 23.8× the market cap of HUM.
- HUM is cheaper on earnings (P/E 43.9 vs 46.9).
- LLY earns a higher return on equity (86% vs 7%).
- LLY is growing revenue faster (39% vs 26%).
- HUM has the higher dividend yield (0.79% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.